Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company dedicated to discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia and endometriosis* and clinical development programs in multiple therapeutic areas. (*in collaboration with AbbVie). www.neurocrine.com